033170 — Signetics Balance Sheet
0.000.00%
- KR₩61bn
- KR₩69bn
- KR₩118bn
Annual balance sheet for Signetics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 50,787 | 33,519 | 20,144 | 13,452 | 1,197 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 23,563 | 34,970 | 30,287 | 18,127 | 15,243 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 92,205 | 105,482 | 91,868 | 49,483 | 27,615 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 65,561 | 69,158 | 81,090 | 75,949 | 50,905 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 166,746 | 182,316 | 193,210 | 153,382 | 105,307 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 54,708 | 53,766 | 57,925 | 31,821 | 33,181 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 60,374 | 58,822 | 61,897 | 35,447 | 36,105 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 106,372 | 123,494 | 131,313 | 117,935 | 69,203 |
Total Liabilities & Shareholders' Equity | 166,746 | 182,316 | 193,210 | 153,382 | 105,307 |
Total Common Shares Outstanding |